| Scott A Swenson, MD | |
|
111 17th Ave E, Alexandria, MN 56308-3703 | |
| (320) 762-6040 | |
| (320) 762-6038 |
| Full Name | Scott A Swenson |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 111 17th Ave E, Alexandria, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891795241 | NPI | - | NPPES |
| 411772562 | Other | MN | TRICARE |
| 16-02279 | Other | MN | MEDICA |
| 411772562 | Other | MN | GREATWEST |
| 965251008799 | Other | MN | PREFERRED ONE |
| 26047 | Other | MN | ARAZ/ AMERICA'S PPO |
| 300137475 | Other | MN | RAILROAD MEDICARE |
| 107115C561 | Other | MN | UCARE OF MINNESOTA |
| 026L8SW | Other | MN | BLUE CROSS BLUE SHIELD |
| 647267200 | Medicaid | MN | |
| HP38512 | Other | MN | HEALTH PARTNERS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25488 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Scott A Swenson, MD 5775 Wayzata Blvd, Suite 400, St Louis Park, MN 55416-1222 Ph: (320) 762-6040 | Scott A Swenson, MD 111 17th Ave E, Alexandria, MN 56308-3703 Ph: (320) 762-6040 |
News Archive
A chemical modification of RNA that can be influenced by diet appears to play a key role in polycystic kidney disease, an inherited disorder that is the fourth leading cause of kidney failure in the U.S., UT Southwestern researchers report in a new study.
Clemson University scientists are working to determine how neurons are generated, which is vital to providing treatment for neurological disorders like Tuberous Sclerosis Complex (TSC).
Mobile devices such as the iPhone can provide valuable assistance to insurance holders in a claims situation, comparison site Constructaquote.com has said.
DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn™ route scouting services. In response to the increasing interest of pharmaceutical customers to outsource the development of robust low-cost manufacturing routes, DSM is offering focused and flexible stand alone route scouting services.
DFine, Inc., developer of minimally invasive solutions for the treatment of vertebral pathologies, announced today the 510(k) clearance of a new platform extension indicated for the palliative treatment of cancer patients. The product, a percutaneous radiofrequency ablation (RFA) device, provides localized tumor necrosis of vertebral body lesions where metastatic disease has spread to the spine causing severe pain and discomfort.
› Verified 7 days ago
Richard D Eiser, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 111 17th Ave E, Alexandria, MN 56308 Phone: 320-762-6040 Fax: 320-762-6038 |